ROCKWELL MEDICAL, INC. Deferred Tax Liabilities, Goodwill and Intangible Assets
ROCKWELL MEDICAL, INC. (RMTI) had Deferred Tax Liabilities, Goodwill and Intangible Assets of $363.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets · last filed 2026-03-26
- 2025-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $363.00K.
- 2024-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $327.00K.
- 2023-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $259.00K.
- 2022-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $224.00K.
| Period end | Deferred Tax Liabilities, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $363.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $327.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $259.00K 10-K · filed 2025-03-20 |
| 2022-12-31 | $224.00K 10-K · filed 2024-03-21 |
| 2021-12-31 | $183.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $155.00K 10-K · filed 2022-04-08 |
| 2019-12-31 | $136.00K 10-K · filed 2021-03-31 |
| 2018-12-31 | $122.00K 10-K · filed 2020-03-17 |
| 2017-12-31 | $98.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $137.00K 10-K · filed 2018-03-15 |
| 2015-12-31 | $167.00K 10-K · filed 2017-03-15 |
| 2014-12-31 | $196.00K 10-K · filed 2016-02-29 |
| 2013-12-31 | $225.00K 10-K · filed 2015-03-03 |
| 2012-12-31 | $272.00K 10-K · filed 2014-03-07 |
| 2011-12-31 | $297.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |